Aldeyra Therapeutics, Inc. (ALDX)
1.205
-0.02
(-1.23%)
USD |
NASDAQ |
Sep 25, 16:00
1.21
0.00 (0.00%)
After-Hours: 19:59
Aldeyra Therapeutics Net Income (TTM) : -23.05M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -23.05M |
| March 31, 2026 | -27.37M |
| December 31, 2025 | -33.85M |
| September 30, 2025 | -43.19M |
| June 30, 2025 | -50.62M |
| March 31, 2025 | -57.70M |
| December 31, 2024 | -55.85M |
| September 30, 2024 | -44.80M |
| June 30, 2024 | -37.87M |
| March 31, 2024 | -30.01M |
| December 31, 2023 | -37.54M |
| September 30, 2023 | -45.69M |
| June 30, 2023 | -52.06M |
| March 31, 2023 | -60.85M |
| December 31, 2022 | -62.02M |
| September 30, 2022 | -64.88M |
| June 30, 2022 | -66.12M |
| March 31, 2022 | -63.27M |
| December 31, 2021 | -57.78M |
| September 30, 2021 | -53.31M |
| June 30, 2021 | -46.39M |
| March 31, 2021 | -38.98M |
| December 31, 2020 | -37.55M |
| September 30, 2020 | -39.42M |
| June 30, 2020 | -49.26M |
| Date | Value |
|---|---|
| March 31, 2020 | -55.07M |
| December 31, 2019 | -60.83M |
| September 30, 2019 | -58.30M |
| June 30, 2019 | -50.40M |
| March 31, 2019 | -46.12M |
| December 31, 2018 | -38.89M |
| September 30, 2018 | -35.21M |
| June 30, 2018 | -29.39M |
| March 31, 2018 | -25.65M |
| December 31, 2017 | -22.34M |
| September 30, 2017 | -20.04M |
| June 30, 2017 | -19.83M |
| March 31, 2017 | -18.82M |
| December 31, 2016 | -18.70M |
| September 30, 2016 | -18.40M |
| June 30, 2016 | -16.99M |
| March 31, 2016 | -14.92M |
| December 31, 2015 | -12.09M |
| September 30, 2015 | -10.18M |
| June 30, 2015 | -8.823M |
| March 31, 2015 | -7.867M |
| December 31, 2014 | -5.520M |
| September 30, 2014 | 5.86M |
| June 30, 2014 | 7.869M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -272.12M |
| Oncolytics Biotech, Inc. | -30.07M |
| Sangamo Therapeutics, Inc. | -123.33M |
| Sarepta Therapeutics, Inc. | -266.10M |
| Anixa Biosciences, Inc. | -10.47M |